Barrett & Company’s Chemours CC Stock Holding History

Barrett & Company’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32K	Sell	60 -10	-14%	-$174	﹤0.01%	599
2025 Q4	$825	Hold	70	–	–	﹤0.01%	624
2025 Q3	$1.11K	Hold	70	–	–	﹤0.01%	604
2025 Q2	$802	Hold	70	–	–	﹤0.01%	612
2025 Q1	$947	Hold	70	–	–	﹤0.01%	585
2024 Q4	$1.18K	Hold	70	–	–	﹤0.01%	576
2024 Q3	$1.42K	Hold	70	–	–	﹤0.01%	547
2024 Q2	$1.58K	Hold	70	–	–	﹤0.01%	554
2024 Q1	$1.84K	Sell	70 -20	-22%	-$570	﹤0.01%	552
2023 Q4	$2.84K	Hold	90	–	–	﹤0.01%	515
2023 Q3	$2.52K	Hold	90	–	–	﹤0.01%	527
2023 Q2	$3.32K	Hold	90	–	–	﹤0.01%	497
2023 Q1	$2.69K	Hold	90	–	–	﹤0.01%	491
2022 Q4	$2.76K	Hold	90	–	–	﹤0.01%	496
2022 Q3	$2.76K	Buy	+90	New	+$2.97K	﹤0.01%	496

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barrett & Company's CC Position: Q1 2026 in Review

Barrett & Company reduced its Chemours (CC) stake by 14% in Q1 2026, selling an estimated $174 and leaving 60 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Barrett & Company first reported a position in CC in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.32K in Q2 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Barrett & Company held 60 shares of Chemours worth $1.32K as of Q1 2026.
Barrett & Company sold 10 Chemours shares in Q1 2026, an estimated $174.
Chemours made up ﹤0.01% of Barrett & Company's portfolio in Q1 2026, its #599 holding.
Barrett & Company first reported a position in Chemours in Q3 2022 and has held it in 15 quarters since.
Barrett & Company's Chemours position peaked at $3.32K in Q2 2023.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.